Lianji Wen

558 total citations
22 papers, 455 citations indexed

About

Lianji Wen is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Lianji Wen has authored 22 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Immunology. Recurrent topics in Lianji Wen's work include RNA modifications and cancer (6 papers), RNA Interference and Gene Delivery (5 papers) and MicroRNA in disease regulation (5 papers). Lianji Wen is often cited by papers focused on RNA modifications and cancer (6 papers), RNA Interference and Gene Delivery (5 papers) and MicroRNA in disease regulation (5 papers). Lianji Wen collaborates with scholars based in China, United States and Australia. Lianji Wen's co-authors include Guofang Guan, Dejun Zhang, Xuejian Zhao, De-Qi Xu, Yueting Shao, Chunshun Jin, Lifang Gao, Xingyi Zhang, Dan Yu and Yanqing Lu and has published in prestigious journals such as Journal of Materials Chemistry B, Otolaryngology and Acta Pharmacologica Sinica.

In The Last Decade

Lianji Wen

21 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lianji Wen China 12 278 177 141 65 41 22 455
Adeline Ledoux United Kingdom 8 341 1.2× 142 0.8× 126 0.9× 78 1.2× 33 0.8× 10 545
Cai M. Roberts United States 12 407 1.5× 138 0.8× 175 1.2× 52 0.8× 49 1.2× 18 591
Chieh-Yang Cheng Taiwan 8 385 1.4× 133 0.8× 185 1.3× 54 0.8× 17 0.4× 12 611
Size Chen China 11 310 1.1× 169 1.0× 178 1.3× 82 1.3× 37 0.9× 29 483
Yanyang Liu China 13 336 1.2× 231 1.3× 100 0.7× 80 1.2× 36 0.9× 28 524
Nirmal Rajasekaran South Korea 10 344 1.2× 126 0.7× 114 0.8× 49 0.8× 36 0.9× 20 526
Tingyang Wang China 4 252 0.9× 189 1.1× 131 0.9× 75 1.2× 26 0.6× 9 394
Malaney R. O’Connell United States 7 187 0.7× 123 0.7× 220 1.6× 40 0.6× 31 0.8× 10 407
Kamal Shaik Fakiruddin Malaysia 10 240 0.9× 105 0.6× 172 1.2× 35 0.5× 30 0.7× 14 429
Hui-Yen Chuang Taiwan 11 246 0.9× 159 0.9× 124 0.9× 109 1.7× 79 1.9× 18 466

Countries citing papers authored by Lianji Wen

Since Specialization
Citations

This map shows the geographic impact of Lianji Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianji Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianji Wen more than expected).

Fields of papers citing papers by Lianji Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lianji Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianji Wen. The network helps show where Lianji Wen may publish in the future.

Co-authorship network of co-authors of Lianji Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Lianji Wen. A scholar is included among the top collaborators of Lianji Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lianji Wen. Lianji Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Ding, Dan Yu, Xueshibojie Liu, et al.. (2020). Targeting laryngeal cancer cells with 5-fluorouracil and curcumin using mesoporous silica nanoparticles. Technology in Cancer Research & Treatment. 19. 1079229762–1079229762. 18 indexed citations
2.
Yu, Dan, Xueshibojie Liu, Guanghong Han, et al.. (2019). The let-7 family of microRNAs suppresses immune evasion in head and neck squamous cell carcinoma by promoting PD-L1 degradation. Cell Communication and Signaling. 17(1). 173–173. 50 indexed citations
3.
Yu, Dan, et al.. (2018). Expression of Programmed Death-Ligand 1 in Laryngeal Carcinoma and its Effects on Immune Cell Subgroup Infiltration. Pathology & Oncology Research. 25(4). 1437–1443. 11 indexed citations
4.
Teng, Bo, Ping’an Ma, Yu Chang, et al.. (2016). Upconversion nanoparticles loaded with eIF4E siRNA and platinum(iv) prodrug to sensitize platinum based chemotherapy for laryngeal cancer and bioimaging. Journal of Materials Chemistry B. 5(2). 307–317. 21 indexed citations
5.
Guan, Guofang, Dejun Zhang, Lianji Wen, et al.. (2016). Overexpression of lncRNA H19/miR-675 promotes tumorigenesis in head and neck squamous cell carcinoma. International Journal of Medical Sciences. 13(12). 914–922. 58 indexed citations
6.
Guan, Guofang, et al.. (2015). Significance of ATP-binding cassette transporter proteins in multidrug resistance of head and neck squamous cell carcinoma. Oncology Letters. 10(2). 631–636. 8 indexed citations
7.
Guan, Guofang, et al.. (2015). Gene expression profiling via bioinformatics analysis reveals biomarkers in laryngeal squamous cell carcinoma. Molecular Medicine Reports. 12(2). 2457–2464. 7 indexed citations
8.
Guan, Guofang, Dejun Zhang, Ying Zheng, et al.. (2015). Abnormal Wnt signaling and overexpression of ABCG2 contributes to drug efflux properties of side population cells in nasopharyngeal carcinoma. Molecular Medicine Reports. 12(3). 4352–4357. 16 indexed citations
9.
Zhao, Lijing, Bo Teng, Lianji Wen, et al.. (2014). mTOR inhibitor AZD8055 inhibits proliferation and induces apoptosis in laryngeal carcinoma.. PubMed. 7(2). 337–47. 22 indexed citations
10.
Guan, Guofang, et al.. (2014). microRNA-423-3p promotes tumor progression via modulation of AdipoR2 in laryngeal carcinoma.. PubMed. 7(9). 5683–91. 41 indexed citations
11.
Guan, Guofang, Dejun Zhang, Lianji Wen, et al.. (2014). Notch 1 signaling pathway is the potential target of novel anticancer drugs for the treatment of human nasopharyngeal cancer. Bangladesh Journal of Pharmacology. 9(4). 1 indexed citations
12.
Wen, Lianji, Lifang Gao, Chunshun Jin, et al.. (2013). Small interfering RNA survivin and GRIM-19 co-expression salmonella plasmid inhibited the growth of laryngeal cancer cells in vitro and in vivo.. PubMed. 6(10). 2071–81. 11 indexed citations
13.
Zhang, Hejia, Tianyu Yu, Lianji Wen, et al.. (2013). Curcumin enhances the effectiveness of cisplatin by suppressing CD133+ cancer stem cells in laryngeal carcinoma treatment. Experimental and Therapeutic Medicine. 6(5). 1317–1321. 36 indexed citations
14.
Guan, Guofang, Liming Liu, Chunshun Jin, et al.. (2013). Salmonella typhimurium Mediated Delivery of Apoptin in Human Laryngeal Cancer. International Journal of Medical Sciences. 10(12). 1639–1648. 32 indexed citations
15.
Yu, Dan, et al.. (2009). [Biological characteristics of highly tumorigenic CD44+CD133+ subpopulation of laryngeal carcinoma cells].. PubMed. 31(2). 99–103. 4 indexed citations
16.
Teng, Bo, et al.. (2007). [Research of 10-23 DNAZyme inhibit the expression of eIF4E genes].. PubMed. 21(12). 552–4. 1 indexed citations
17.
Gao, Lifang, Lianji Wen, Hao Yu, et al.. (2006). Knockdown of Stat3 expression using RNAi inhibits growth of laryngeal tumors in vivo. Acta Pharmacologica Sinica. 27(3). 347–352. 31 indexed citations
18.
Gao, Lifang, De-Qi Xu, Lianji Wen, et al.. (2005). Inhibition of STAT3 expression by siRNA suppresses growth and induces apoptosis in laryngeal cancer cells. Acta Pharmacologica Sinica. 26(3). 377–383. 65 indexed citations
19.
Guan, Guofang, Ningyi Jin, Zhiqiang Mi, et al.. (2005). [Construction of the nucleic vaccine pVVP3L-18HN and its antitumor effect on human laryngeal carcinoma].. PubMed. 40(8). 566–70. 3 indexed citations
20.
Wen, Lianji, et al.. (2004). Expression and implication of survivin gene in laryngeal carcinoma. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adeline Ledoux Breakdown of academic impact, for papers by Cai M. Roberts Breakdown of academic impact, for papers by Chieh-Yang Cheng Breakdown of academic impact, for papers by Size Chen Breakdown of academic impact, for papers by Yanyang Liu Breakdown of academic impact, for papers by Nirmal Rajasekaran Breakdown of academic impact, for papers by Tingyang Wang Breakdown of academic impact, for papers by Malaney R. O’Connell Breakdown of academic impact, for papers by Kamal Shaik Fakiruddin Breakdown of academic impact, for papers by Hui-Yen Chuang
Rankless by CCL
2026